Market Overview:
The global prefilled vaccine syringes market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for vaccines, rising prevalence of chronic diseases, and technological advancements in prefilled vaccine syringes. Based on type, the global prefilled vaccine syringes market can be segmented into with needles and without needles. The with needles segment is expected to account for a larger share of the global prefilled vaccine syringes market than the without needles segment during the forecast period from 2018 to 2030. This can be attributed to factors such as ease of use and accuracy offered by with needle prefilled vaccine syringes over without needle ones. Based on application, the global pre-filled vaccine syringe market can be divided into hospitals and clinics.
Product Definition:
Prefilled syringes are syringes that have already been filled with a dose of medication. They are typically used to inject children with vaccines. Prefilled syringes are important because they make it easy to give children the correct dose of vaccine, and they help ensure that each child receives the same dose of vaccine.
With Needles:
With Needles, it’s usage and growth factor in Prefilled Vaccine Syringes market is expected to witness significant growth over the forecast period. With needles are used for drawing blood from patients and also used for removing fluid from swelling or injured area. It helps in injecting medicines into the body as well as removes fluids like blood, pus, and other body fluids from wounds.
W/O Needles:
The global What is W/O needles and it's usage in Prefilled Vaccine Syringes market size was valued at USD 6.5 billion in 2016 and is expected to grow at a CAGR of XX% over the forecast period. The increasing prevalence of chronic diseases such as diabetes, cancer, autoimmune diseases & other disorders coupled with rising demand for vaccines globally are some major factors driving the growth of this industry.
Application Insights:
Based on the application, the global prefilled vaccine syringes market is segmented into hospitals and clinics. Hospitals held the largest share of over 70.0% in 2017 owing to factors such as a high volume of patient admissions and an increase in government-sponsored healthcare programs that drive demand for vaccines. In addition, hospitals are considered to be one of the highest risk settings for disease transmission due to improper hygiene and sanitation conditions which further drives demand for vaccination at this setting.
The clinics segment is expected to grow significantly over the forecast period owing to an increase in travelers visiting countries across Latin America, Asia Pacific and Africa regions who require pre-travel health consultations or vaccinations before departure from home country or before visa issuance at border crossings by respective governments authorities responsible for foreign travel matters (i.e., U.S., Canada).
Regional Analysis:
North America dominated the global prefilled vaccine syringes market in 2017. This can be attributed to factors such as the presence of a large number of players, high investment in R&D, and increasing demand for preventive healthcare measures. Moreover, growing efforts by government bodies to increase immunization rates are expected to fuel product demand over the forecast period. For instance, according to data published by Centers for Disease Control & Prevention (CDC) in 2016’s Vaccines Prevent Diseases Volume 2: Recommendations for Adult Immunization Schedules from 2014 Through 2020; U.S has one of the highest vaccination compliance rates with an estimated coverage rate of 92%.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to rising investments by governments.
Growth Factors:
- Increasing incidence of infectious diseases: The increasing incidence of infectious diseases is one of the key growth drivers for the prefilled vaccine syringes market. This is because the prefilled vaccine syringes offer a more convenient and safe option for administering vaccines as compared to traditional vials and needles.
- Technological advancements: The technological advancements in prefilled vaccine syringes are another key factor driving the growth of this market. These advancements have led to the development of new types of prefilled vaccine syringes that are easier to use and administer vaccines accurately.
- Rising demand for self-injection devices: The rising demand for self-injection devices is another major driver for the growth of the prefilled vaccine syringes market. This is because self-injection devices offer a more convenient and safe option for administering vaccines than traditional vials and needles, which can lead to inaccurate dosing or even needle stick injuries if not used properly.
Scope Of The Report
Report Attributes
Report Details
Report Title
Prefilled Vaccine Syringes Market Research Report
By Type
With Needles, W/O Needles
By Application
Hospitals, Clinics
By Companies
BD, Gerresheimer, SCHOTT AG, Nipro Corporation, Stevanato, Baxter Healthcare, Vetter, Catalent, Taisei Kako, Roselabs Group, West Pharmaceutical Services
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
168
Number of Tables & Figures
118
Customization Available
Yes, the report can be customized as per your need.
Global Prefilled Vaccine Syringes Market Report Segments:
The global Prefilled Vaccine Syringes market is segmented on the basis of:
Types
With Needles, W/O Needles
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- BD
- Gerresheimer
- SCHOTT AG
- Nipro Corporation
- Stevanato
- Baxter Healthcare
- Vetter
- Catalent
- Taisei Kako
- Roselabs Group
- West Pharmaceutical Services
Highlights of The Prefilled Vaccine Syringes Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- With Needles
- W/O Needles
- By Application:
- Hospitals
- Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Prefilled Vaccine Syringes Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Prefilled vaccine syringes are used to inject vaccines into the body. They come in a variety of sizes and can be filled with different types of vaccines.
Some of the major players in the prefilled vaccine syringes market are BD, Gerresheimer, SCHOTT AG, Nipro Corporation, Stevanato, Baxter Healthcare, Vetter, Catalent, Taisei Kako, Roselabs Group, West Pharmaceutical Services.
The prefilled vaccine syringes market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Prefilled Vaccine Syringes Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Prefilled Vaccine Syringes Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Prefilled Vaccine Syringes Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Prefilled Vaccine Syringes Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Prefilled Vaccine Syringes Market Size & Forecast, 2020-2028
4.5.1 Prefilled Vaccine Syringes Market Size and Y-o-Y Growth
4.5.2 Prefilled Vaccine Syringes Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 With Needles
5.2.2 W/O Needles
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Prefilled Vaccine Syringes Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Prefilled Vaccine Syringes Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 With Needles
9.6.2 W/O Needles
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 With Needles
10.6.2 W/O Needles
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 With Needles
11.6.2 W/O Needles
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 With Needles
12.6.2 W/O Needles
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 With Needles
13.6.2 W/O Needles
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Prefilled Vaccine Syringes Market: Competitive Dashboard
14.2 Global Prefilled Vaccine Syringes Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 BD
14.3.2 Gerresheimer
14.3.3 SCHOTT AG
14.3.4 Nipro Corporation
14.3.5 Stevanato
14.3.6 Baxter Healthcare
14.3.7 Vetter
14.3.8 Catalent
14.3.9 Taisei Kako
14.3.10 Roselabs Group
14.3.11 West Pharmaceutical Services
